Wilbanks Smith & Thomas Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,000
Closed -$200K 515
2023
Q1
$200K Hold
1,000
0.01% 490
2022
Q4
$238K Hold
1,000
0.01% 433
2022
Q3
$200K Buy
+1,000
New +$200K 0.01% 449